812 results on '"Wei, Guoqing"'
Search Results
2. Better pre-transplant treatment options for TP53-mutated MDS: cytoreductive or non-cytoreductive therapy?
3. A rare KMT2A::CBL transcript in an acute monoblastic leukemia patient with an unfavorable outcome
4. Author Correction: CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
5. Cytokine-based models for efficient differentiation between infection and cytokine release syndrome in patients with hematological malignancies
6. Impact of additional cytogenetic aberrations at diagnosis on prognosis of adults patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: a retrospective analysis
7. Bibliometric and Visualization Analysis of Research Hotspots in Field of Smart Water Conservancy
8. Efficient degradation and recycling of carbon fiber reinforced epoxy composite wastes under mild conditions by constructing dual dynamic covalent networks
9. Annealing characteristics and mechanism interpretation of high-performance swaged W-Y2O3 alloy
10. Bulk fabrication of tungsten-based composite materials with excellent low-temperature strength and ductility through powder innovation
11. Study and theoretical explanation on high-temperature strength of ODS-W alloy
12. Efficient biosynthesis of creatine by whole-cell catalysis from guanidinoacetic acid in Corynebacterium glutamicum
13. Degradable, intrinsically flame-retardant, low-water-absorbing vanillin-derived epoxy thermoset with a Schiff base structure
14. DPIM-based global reliability analysis method for the cable-stayed bridges and the determination of global target reliability index
15. Challenges and Prospects of Hydrogen Energy Storage Under the Background of Low-carbon Transformation of Power Industry
16. A distinct cytokine network distinguishes chimeric antigen receptor T cell (CAR-T)–associated hemophagocytic lymphohistiocytosis-like toxicity (carHLH) from severe cytokine release syndrome following CAR-T therapy
17. IodoTMT-labeled redox proteomics reveals the involvement of oxidative post-translational modification in response to para-hydroxybenzoic acid and hydrogen peroxide stresses in poplar
18. Safety and efficacy of CRISPR-based non-viral PD1 locus specifically integrated anti-CD19 CAR-T cells in patients with relapsed or refractory Non-Hodgkin's lymphoma: a first-in-human phase I study
19. Genetically modified CD7-targeting allogeneic CAR-T cell therapy with enhanced efficacy for relapsed/refractory CD7-positive hematological malignancies: a phase I clinical study
20. GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial
21. Cytokine profiles are associated with prolonged hematologic toxicities after B-cell maturation antigen targeted chimeric antigen receptor–T-cell therapy
22. Proteomic analysis reveals allelopathic responsive mechanisms for para-hydroxybenzoic acid in poplars
23. Secondary donor-derived CD19 CAR-T therapy is safe and efficacious in acute lymphoblastic leukemia with extramedullary relapse after first autologous CAR-T therapy
24. Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL
25. Predictive value of next-generation sequencing-based minimal residual disease after CAR-T cell therapy
26. A comparative analysis of photosynthetic function and reactive oxygen species metabolism responses in two hibiscus cultivars under saline conditions
27. Characterization and Phylogenetic Analysis of the Complete Mitochondrial Genome of Saturnia japonica
28. Study on the mechanical response characteristics of sandstone under elasticity plasticity and full path unloading after peak stress.
29. Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia.
30. Liquid crystal self-assembly of upconversion nanorods enriched by depletion forces for mesostructured material preparation
31. CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
32. Bone marrow mesenchymal stem cells overexpressing hepatocyte growth factor ameliorate hypoxic–ischemic brain damage in neonatal rats
33. Constructing 3D Bi/Bi4O5I2 microspheres with rich oxygen vacancies by one-pot solvothermal method for enhancing photocatalytic activity on mercury removal
34. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020 : retrospective cohort study
35. A 3-armed multicenter randomized controlled trial: Placental Transfusion in Very Preterm Infants (PT-VPI)
36. Single-Cell Transcriptomic Analysis Reveals BCMA CAR-T Cell Dynamics in a Patient with Refractory Primary Plasma Cell Leukemia
37. CRS-related coagulopathy in BCMA targeted CAR-T therapy: a retrospective analysis in a phase I/II clinical trial
38. A Kazal-type serine protease inhibitor mediates innate immunity in wild silkworm Actias selene Hübner
39. CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challenges
40. Stepwise dual targeting and dual responsive polymer micelles for mitochondrion therapy
41. Sequential CD7 CAR T-Cell Therapy and Allogeneic HSCT without GVHD Prophylaxis
42. Impact of Additional Cytogenetic Aberrations at Diagnosis on Prognosis of Adults Patients with Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation：A Retrospective Analysis
43. Mechanical Control of Quantum Transport in Graphene
44. Clinical characterization and risk factors associated with cytokine release syndrome induced by COVID-19 and chimeric antigen receptor T-cell therapy
45. Response to Comment on “Lung Transplantation for Elderly Patients With End-stage COVID–19 Pneumonia“
46. Maintenance sorafenib is superior to prophylactic donor lymphocyte infusion at improving the prognosis of acute myeloid leukemia with FMS-like tyrosine kinase 3 internal tandem duplication after allogeneic hematopoietic stem cell transplantation
47. CD19/CD22 chimeric antigen receptor T-cell therapy for refractory acute B-cell lymphoblastic leukemia with FLT3-ITD mutations
48. Measuring the global, regional, and national burden of multiple myeloma from 1990 to 2019
49. Inflammation-related genes S100s, RNASE3, and CYBB and risk of leukemic transformation in patients with myelodysplastic syndrome with myelofibrosis
50. Near-infrared light switching nitric oxide nanoemitter for triple-combination therapy of multidrug resistant cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.